
Formats: [HTML](/news/2013/02/24/anemia-drug-omontys-is-recalled-due-to-reports-of-fatal-anaphylactic-reactions-in-0-02-of-patients.html)  [JSON](/news/2013/02/24/anemia-drug-omontys-is-recalled-due-to-reports-of-fatal-anaphylactic-reactions-in-0-02-of-patients.json)  [XML](/news/2013/02/24/anemia-drug-omontys-is-recalled-due-to-reports-of-fatal-anaphylactic-reactions-in-0-02-of-patients.xml)  

### [2013-02-24](/news/2013/02/24/index.md)

##### Anemia
# Anemia drug Omontys is recalled due to reports of fatal anaphylactic reactions in 0.02% of patients. 

All lots of the new anemia drug peginesatide (Omontys) have been recalled because of severe hypersensitivity reactions -- some fatal -- observed after the drug was approved last March.


### Sources:

1. [Medpage Today](http://www.medpagetoday.com/HematologyOncology/Anemia/37509)
1. [Cover Image](https://clf1.medpagetoday.com/assets/images/defaultLede.png)
